Filing Details
- Accession Number:
- 0001179110-15-012103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-13 19:49:47
- Reporting Period:
- 2015-08-11
- Filing Date:
- 2015-08-13
- Accepted Time:
- 2015-08-13 19:49:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1423824 | Alder Biopharmaceuticals Inc | ALDR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1033501 | M Stephen Dow | C/O Sevin Rosen Funds 13355 Noel Road, Suite 1350 Dallas TX 75240 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-08-11 | 115,358 | $40.40 | 2,183,205 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2015-08-12 | 97,109 | $40.03 | 2,086,096 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2015-08-12 | 1,795,752 | $0.00 | 290,344 | No | 4 | J | Indirect | See Footnote |
Common Stock | Acquisiton | 2015-08-12 | 8,110 | $0.00 | 298,454 | No | 4 | J | Indirect | See Footnote |
Common Stock | Acquisiton | 2015-08-12 | 42 | $0.00 | 298,496 | No | 4 | J | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | J | Indirect | See Footnote |
No | 4 | J | Indirect | See Footnote |
No | 4 | J | Indirect | See Footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Total Common Shares of 2,183,205 represents 46 shares owned directly by SRB Associates IX L.P. ("SRBAIX"), 1,860,948 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX"), 48,131 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRFIX AFF") and 274,080 shares owned directly by The Dow Family Trust the ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Total Common Shares of 2,086,096 represents 46 shares owned directly by SRBAIX, 1,765,877 shares owned directly by SRFIX, 46,093 shares owned directly by SRFIX AFF, and 274,080 shares owned directly by The Dow Family Trust the ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.
- Represents a pro-rata in-kind distribution, without additional consideration, of 1,750,000 shares of Common Stock of the Issuer by SRFIX and 45,752 shares of Common Stock of the Issuer by SRIXAFF.
- Total Common Shares of 290,344 represents 46 shares owned by SRB Associates IX L.P., 15,877 shares owned directly by SRFIX, 341 shares owned directly by SRIX AFF, and 274,080 shares owned directly by The Dow Family Trust the ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.
- Represents the receipt of shares by the Dow Trust of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution described in footnote (5) above.
- Total Common Shares of 298,454 represents 46 shares owned by SRB Associates IX L.P., 15,877 shares owned directly by SRFIX, 341 shares owned directly by SRIX AFF, and 282,190 shares owned directly by The Dow Family Trust the ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.
- Represents the receipt of shares by SRBAIX of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution described in footnote (5) above.
- Total Common Shares of 298,496 represents 88 shares owned by SRB Associates IX L.P., 15,877 shares owned directly by SRFIX, 341 shares owned directly by SRIX AFF, and 282,190 shares owned directly by The Dow Family Trust the ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.